C3G overexpression in glomerular epithelial cells during anti-GBM-induced glomerulonephritis

Kidney International

Volumn 75, Issue 1, 2009, Pages 31-40

  Rufanova, Victoriya A ^a   Lianos, Elias ^b   Alexanian, Anna ^a   Sorokina, Elena ^a   Sharma, Mukut ^a   McGinty, Ann ^a,c   Sorokin, Andrey ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

C3G; Glomerular epithelial cells; Glomerulonephritis; Small GTPases

Indexed keywords

ENDOTHELIN; GLOMERULUS BASEMENT MEMBRANE ANTIBODY; GUANINE NUCLEOTIDE EXCHANGE FACTOR; GUANINE NUCLEOTIDE EXCHANGE FACTOR C3G; GUANOSINE TRIPHOSPHATASE; GUANOSINE TRIPHOSPHATASE RRAS; RAP1 PROTEIN; UNCLASSIFIED DRUG; UVOMORULIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL MIGRATION; CELL SPREADING; CELL STRUCTURE; CONTROLLED STUDY; GLOMERULONEPHRITIS; GLOMERULUS EPITHELIUM; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; AUTOANTIBODIES; CADHERINS; CELL ADHESION; CELL MOVEMENT; EPITHELIAL CELLS; GENE EXPRESSION; GLOMERULONEPHRITIS; GUANINE NUCLEOTIDE-RELEASING FACTOR 2; KIDNEY GLOMERULUS; MALE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 58049202236     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/ki.2008.448     Document Type: Article

References (52)

1. Griffin SV, Petermann AT, Durvasula RV et al. Podocyte proliferation and differentiation in glomerular disease: role of cell-cycle regulatory proteins. Nephrol Dial Transplant 2003; 18(Suppl 6): vi8-vi13.
2. Bariety J, Bruneval P, Meyrier A et al. Podocyte involvement in human immune crescentic glomerulonephritis. Kidney Int 2005; 68: 1109-1119.
3. Jefferson JA, Johnson RJ. Experimental mesangial proliferative glomerulonephritis (the anti-Thy-1.1 model). J Nephrol 1999; 12: 297-307.
4. Zeghouf M, Guibert B, Zeeh JC et al. Arf, Sec7 and Brefeldin A: a model towards the therapeutic inhibition of guanine nucleotide-exchange factors. Biochem Soc Trans 2005; 33: 1265-1268.
5. Voss AK, Gruss P, Thomas T. The guanine nucleotide exchange factor C3G is necessary for the formation of focal adhesions and vascular maturation. Development 2003; 130: 355-367.
6. Ohba Y, Ikuta K, Ogura A et al. Requirement for C3G-dependent Rap1 activation for cell adhesion and embryogenesis. EMBO J 2001; 20: 3333-3341.
7. Voss AK, Krebs DL, Thomas T. C3G regulates the size of the cerebral cortex neural precursor population. EMBO J 2006; 25: 3652-3663.
8. York RD, Yao H, Dillon T et al. Rap1 mediates sustained MAP kinase activation induced by nerve growth factor. Nature 1998; 392: 622-626.
9. Bokemeyer D, Guglielmi KE, McGinty A et al. Activation of extracellular signal-regulated kinase in proliferative glomerulonephritis in rats. J Clin Invest 1997; 100: 582-588.
10. Kooistra MR, Dube N, Bos JL. Rap1: a key regulator in cell-cell junction formation. J Cell Sci 2007; 120: 17-22.
11. Hattori M, Minato N. Rap1 GTPase: functions, regulation, and malignancy. J Biochem 2003; 134: 479-484.
12. Wang Y, Sheibani N. PECAM-1 isoform-specific activation of MAPK/ERKs and small GTPases: implications in inflammation and angiogenesis. J Cell Biochem 2006; 98: 451-468.
13. Bos JL, de Bruyn K, Enserink J et al. The role of Rap1 in integrin-mediated cell adhesion. Biochem Soc Trans 2003; 31: 83-86.
14. Ada-Nguema AS, Xenias H, Sheetz MP et al. The small GTPase R-Ras regulates organization of actin and drives membrane protrusions through the activity of PLCepsilon. J Cell Sci 2006; 119: 1307-1319.
15. Konstantinov IE, Coles JG, Boscarino C et al. Gene expression profiles in children undergoing cardiac surgery for right heart obstructive lesions. J Thorac Cardiovasc Surg 2004; 127: 746-754.
16. Habib SL, Phan MN, Patel SK et al. Reduced constitutive 8-oxoguanine-DNA glycosylase expression and impaired induction following oxidative DNA damage in the tuberin deficient Eker rat. Carcinogenesis 2003; 24: 573-582.
17. Thorner PS, Ho M, Eremina V et al. Podocytes contribute to the formation of glomerular crescents. J Am Soc Nephrol 2008; 19: 495-502.
18. Floege J, Eng E, Young BA et al. Factors involved in the regulation of mesangial cell proliferation in vitro and in vivo. Kidney Int Suppl 1993; 39: S47-S54.
19. Okino K, Nagai H, Nakayama H et al. Inactivation of Crk SH3 domain-binding guanine nucleotide-releasing factor (C3G) in cervical squamous cell carcinoma. Int J Gynecol Cancer 2006; 16: 763-771.
20. Gutierrez-Berzal J, Castellano E, Martin-Encabo S et al. Characterization of p87C3G, a novel, truncated C3G isoform that is overexpressed in chronic myeloid leukemia and interacts with Bcr-Abl. Exp Cell Res 2006; 312: 938-948.
21. Hirata T, Nagai H, Koizumi K et al. Amplification, up-regulation and overexpression of C3G (CRK SH3 domain-binding guanine nucleotide-releasing factor) in non-small cell lung cancers. J Hum Genet 2004; 49: 290-295.
22. Kohan DE. Endothelins in the normal and diseased kidney. Am J Kidney Dis 1997; 29: 2-26.
23. Simonson MS, Dunn MJ. Endothelin peptides and the kidney. Annu Rev Physiol 1993; 55: 249-265.
24. Wu H, Wang H, Wang Y et al. The role for endothelin in mesangial proliferative glomerulonephritis. J Tongji Med Univ 1998; 18: 122-125.
25. Gomez-Garre D, Largo R, Liu XH et al. An orally active ETA/ETB receptor antagonist ameliorates proteinuria and glomerular lesions in rats with proliferative nephritis. Kidney Int 1996; 50: 962-972.
26. Takaya A, Kamio T, Masuda M et al. R-Ras regulates exocytosis by Rgl2/Rlf-mediated activation of RalA on endosomes. Mol Biol Cell 2007; 18: 1850-1860.
27. Rastaldi MP, Armelloni S, Berra S et al. Glomerular podocytes contain neuron-like functional synaptic vesicles. FASEB J 2006; 20: 976-978.
28. Roselli S, Moutkine I, Gribouval O et al. Plasma membrane targeting of podocin through the classical exocytic pathway: effect of NPHS2 mutations. Traffic 2004; 5: 37-44.
29. Bremnes T, Paasche JD, Mehlum A et al. Regulation and intracellular trafficking pathways of the endothelin receptors. J Biol Chem 2000; 275: 17596-17604.
30. Guerrero C, Martin-Encabo S, Fernandez-Medarde A et al. C3G-mediated suppression of oncogene-induced focus formation in fibroblasts involves inhibition of ERK activation, cyclin A expression and alterations of anchorage-independent growth. Oncogene 2004; 23: 4885-4893.
31. Riedl JA, Brandt DT, Batlle E et al. Down-regulation of Rap1 activity is involved in ephrinB1-induced cell contraction. Biochem J 2005; 389: 465-469.
32. Elowe S, Holland SJ, Kulkarni S et al. Downregulation of the Ras-mitogen-activated protein kinase pathway by the EphB2 receptor tyrosine kinase is required for ephrin-induced neurite retraction. Mol Cell Biol 2001; 21: 7429-7441.
33. Hughes PE, Renshaw MW, Pfaff M et al. Suppression of integrin activation: a novel function of a Ras/Raf-initiated MAP kinase pathway. Cell 1997; 88: 521-530.
34. Sethi T, Ginsberg MH, Downward J et al. The small GTP-binding protein R-Ras can influence integrin activation by antagonizing a Ras/Raf-initiated integrin suppression pathway. Mol Biol Cell 1999; 10: 1799-1809.
35. Keely PJ, Rusyn EV, Cox AD et al. R-Ras signals through specific integrin alpha cytoplasmic domains to promote migration and invasion of breast epithelial cells. J Cell Biol 1999; 145: 1077-1088.
36. Holly SP, Larson MK, Parise LV. The unique N-terminus of R-ras is required for Rac activation and precise regulation of cell migration. Mol Biol Cell 2005; 16: 2458-2469.
37. Dail M, Richter M, Godement P et al. Eph receptors inactivate R-Ras through different mechanisms to achieve cell repulsion. J Cell Sci 2006; 119: 1244-1254.
38. Petermann A, Floege J. Podocyte damage resulting in podocyturia: a potential diagnostic marker to assess glomerular disease activity. Nephron Clin Pract 2007; 106: c61-c66.
39. Kriz W, LeHir M. Pathways to nephron loss starting from glomerular diseases-insights from animal models. Kidney Int 2005; 67: 404-419.
40. Patey N, Lesavre P, Halbwachs-Mecarelli L et al. Adhesion molecules in human crescentic glomerulonephritis. J Pathol 1996; 179: 414-420.
41. Etienne S, Adamson P, Greenwood J et al. ICAM-1 signaling pathways associated with Rho activation in microvascular brain endothelial cells. J Immunol 1998; 161: 5755-5761.
42. Ng YY, Fan JM, Mu W et al. Glomerular epithelial-myofibroblast transdifferentiation in the evolution of glomerular crescent formation. Nephrol Dial Transplant 1999; 14: 2860-2872.
43. Usui J, Kanemoto K, Tomari S et al. Glomerular crescents predominantly express cadherin-catenin complex in pauci-immune-type crescentic glomerulonephritis. Histopathology 2003; 43: 173-179.
44. Hogan C, Serpente N, Cogram P et al. Rap1 regulates the formation of E-cadherin-based cell-cell contacts. Mol Cell Biol 2004; 24: 6690-6700.
45. Asano T, Niimura F, Pastan I et al. Permanent genetic tagging of podocytes: fate of injured podocytes in a mouse model of glomerular sclerosis. J Am Soc Nephrol 2005; 16: 2257-2262.
46. Rosano L, Spinella F, Di Castro V et al. Endothelin-1 is required during epithelial to mesenchymal transition in ovarian cancer progression. Exp Biol Med (Maywood) 2006; 231: 1128-1131.
47. Misra RP. Isolation of glomeruli from mammalian kidneys by graded sieving. Am J Clin Pathol 1972; 58: 135-139.
48. Liebau MC, Lang D, Bohm J et al. Functional expression of the renin-angiotensin system in human podocytes. Am J Physiol Renal Physiol 2006; 290: F710-F719.
49. Sharma R, Lovell HB, Wiegmann TB et al. Vasoactive substances induce cytoskeletal changes in cultured rat glomerular epithelial cells. J Am Soc Nephrol 1992; 3: 1131-1138.
50. Sharma R, Sharma M, Vamos S et al. Both subtype 1 and 2 receptors of angiotensin II participate in regulation of intracellular calcium in glomerular epithelial cells. J Lab Clin Med 2001; 138: 40-49.
51. Kreisberg JI, Hoover RL, Karnovsky MJ. Isolation and characterization of rat glomerular epithelial cells in vitro. Kidney Int 1978; 14: 21-30.
52. Foschi M, Chari S, Dunn MJ et al. Biphasic activation of p21ras by endothelin-1 sequentially activates the ERK cascade and phosphatidylinositol 3-kinase. EMBO J 1997; 16: 6439-6451.